RIP140 in monocytes/macrophages regulates osteoclast differentiation and bone homeostasis.

Osteolytic bone diseases, such as osteoporosis, are characterized by diminished bone quality and increased fracture risk. The therapeutic challenge remains to maintain bone homeostasis with a balance between osteoclast-mediated resorption and osteoblast-mediated formation. Osteoclasts are formed by the fusion of monocyte/macrophage-derived precursors. Here we report, to our knowledge for the first time, that receptor-interacting protein 140 (RIP140) expression in osteoclast precursors and its protein regulation are crucial for osteoclast differentiation, activity, and coupled bone formation. In mice, monocyte/macrophage-specific knockdown of RIP140 (mϕRIP140KD) resulted in a cancellous osteopenic phenotype with significantly increased bone resorption and reduced bone formation. Osteoclast precursors isolated from mϕRIP140KD mice had significantly increased differentiation potential. Furthermore, conditioned media from mϕRIP140KD primary osteoclast cultures significantly suppressed osteoblast differentiation. This suppressive activity was effectively and rapidly terminated by specific Syk-stimulated RIP140 protein degradation. Mechanistic analysis revealed that RIP140 functions primarily by inhibiting osteoclast differentiation through forming a transcription-suppressor complex with testicular receptor 4 (TR4) to repress osteoclastogenic genes. These data reveal that monocyte/macrophage RIP140/TR4 complexes may serve as a critical transcription regulatory complex maintaining homeostasis of osteoclast differentiation, activity, and coupling with osteoblast formation. Accordingly, we propose a potentially novel therapeutic strategy, specifically targeting osteoclast precursor RIP140 protein in osteolytic bone diseases.

[1]  International Association for the Study of Obesity , 2018, The Grants Register 2019.

[2]  R. Turner,et al.  Influence of body weight on bone mass, architecture and turnover. , 2016, The Journal of endocrinology.

[3]  Michael Kyba,et al.  DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes , 2016, Nucleic acids research.

[4]  S. Sacco,et al.  Combined high-fat-resveratrol diet and RIP140 knockout mice reveal a novel relationship between elevated bone mitochondrial content and compromised bone microarchitecture, bone mineral mass, and bone strength in the tibia. , 2016, Molecular nutrition & food research.

[5]  S. Khosla,et al.  Osteoclast TGF‐β Receptor Signaling Induces Wnt1 Secretion and Couples Bone Resorption to Bone Formation , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  Kenneth A. Philbrick,et al.  Paradoxical Effects of Partial Leptin Deficiency on Bone in Growing Female Mice , 2015, Anatomical record.

[7]  C. Rosen,et al.  Energy Excess, Glucose Utilization, and Skeletal Remodeling: New Insights , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  Li-Na Wei,et al.  Receptor-Interacting Protein 140 Orchestrates the Dynamics of Macrophage M1/M2 Polarization , 2015, Journal of Innate Immunity.

[9]  W. Zou,et al.  Absence of Dap12 and the αvβ3 integrin causes severe osteopetrosis , 2015, The Journal of cell biology.

[10]  Shelly K McCrady-Spitzer,et al.  Reducing RIP140 Expression in Macrophage Alters ATM Infiltration, Facilitates White Adipose Tissue Browning, and Prevents High-Fat Diet–Induced Insulin Resistance , 2014, Diabetes.

[11]  R. Xia,et al.  Screening and functional microarray analysis of differentially expressed genes related to osteoporosis. , 2014, Genetics and molecular research : GMR.

[12]  Jaspinder Kaur.  A Comprehensive Review on Metabolic Syndrome , 2014, Cardiology research and practice.

[13]  E. Siris,et al.  World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2014): Oral Communication Abstracts , 2014, Osteoporosis International.

[14]  F. Vázquez,et al.  Estrogen-related genes and postmenopausal osteoporosis risk , 2012, Climacteric : the journal of the International Menopause Society.

[15]  C. Rosen,et al.  New insights into osteoporosis: the bone–fat connection , 2012, Journal of internal medicine.

[16]  Chawnshang Chang,et al.  Reduced osteoblast activity in the mice lacking TR4 nuclear receptor leads to osteoporosis , 2012, Reproductive Biology and Endocrinology.

[17]  D. Greaves,et al.  NF-κB-mediated degradation of the co-activator RIP140 regulates inflammatory response and contributes to endotoxin tolerance , 2012, Nature Immunology.

[18]  Jeroen A. A. Demmers,et al.  An Oct4-Centered Protein Interaction Network in Embryonic Stem Cells , 2010, Cell stem cell.

[19]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[20]  E. Bradley,et al.  TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival. , 2008, Experimental cell research.

[21]  W. Zou,et al.  Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. , 2007, The Journal of cell biology.

[22]  W. Zou,et al.  Syk, c-Src, the αvβ3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption , 2007, The Journal of Cell Biology.

[23]  P. Vestergaard,et al.  Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis , 2007, Osteoporosis International.

[24]  Pawan Gupta,et al.  Modulation of Testicular Receptor 4 Activity by Mitogen-activated Protein Kinase-mediated Phosphorylation* , 2006, Molecular & Cellular Proteomics.

[25]  M. Wilkinson,et al.  Tissue-specific and cell type–specific RNA interference in vivo , 2006, Nature Protocols.

[26]  K. Mchugh,et al.  Cloning and characterization of osteoclast precursors from the raw264.7 cell line , 2006, In Vitro Cellular & Developmental Biology - Animal.

[27]  F. Morón,et al.  Multilocus analysis of estrogen-related genes in Spanish postmenopausal women suggests an interactive role of ESR1, ESR2 and NRIP1 genes in the pathogenesis of osteoporosis. , 2006, Bone.

[28]  T. Martin,et al.  Osteoclast-derived activity in the coupling of bone formation to resorption. , 2005, Trends in molecular medicine.

[29]  H. Uno,et al.  Growth retardation and abnormal maternal behavior in mice lacking testicular orphan nuclear receptor 4. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[30]  T. Taniguchi,et al.  Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis , 2004, Nature.

[31]  Sakae Tanaka,et al.  Association of sustained ERK activity with integrin beta3 induction during receptor activator of nuclear factor kappaB ligand (RANKL)-directed osteoclast differentiation. , 2003, Experimental cell research.

[32]  David L. Lacey,et al.  Osteoclast differentiation and activation , 2003, Nature.

[33]  Hiroshi Takayanagi,et al.  Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. , 2002, Developmental cell.

[34]  S. Gordon,et al.  The use of human CD68 transcriptional regulatory sequences to direct high‐level expression of class A scavenger receptor in macrophages in vitro and in vivo , 2001, Immunology.

[35]  S. Teitelbaum,et al.  Bone resorption by osteoclasts. , 2000, Science.

[36]  T. Martin,et al.  Therapeutic approaches to bone diseases. , 2000, Science.

[37]  W. Dougall,et al.  RANK is essential for osteoclast and lymph node development. , 1999, Genes & development.

[38]  Chawnshang Chang,et al.  Negative Feedback Control of the Retinoid-Retinoic Acid/Retinoid X Receptor Pathway by the Human TR4 Orphan Receptor, a Member of the Steroid Receptor Superfamily* , 1998, The Journal of Biological Chemistry.

[39]  E. Canalis.  Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. , 1996, The Journal of clinical endocrinology and metabolism.

[40]  D. Rao,et al.  Bone Loss and Bone Turnover in Diabetes , 1995, Diabetes.

[41]  S. Cummings,et al.  Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. , 1995, The New England journal of medicine.

[42]  S. Nishikawa,et al.  The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene , 1990, Nature.

[43]  Xiaojie Chu,et al.  Involvement of receptor-interacting protein 140 in estrogen-mediated osteoclasts differentiation, apoptosis, and bone resorption , 2016, The Journal of Physiological Sciences.

[44]  R. Turner,et al.  Histological analysis of bone. , 2008, Methods in molecular biology.

[45]  H. Minuk,et al.  Metabolic syndrome. , 2005, Journal of insurance medicine.

[46]  T. Hefferan,et al.  Animal Models For Osteoporosis , 2004, Reviews in Endocrine and Metabolic Disorders.

[47]  A. Parfitt.  The coupling of bone formation to bone resorption: a critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis. , 1982, Metabolic bone disease & related research.